Is the business good?
How good a business is SGRY?
Surgery Partners, Inc. earns 5.8% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
5.8%
Return on invested capital · cost of capital 9.0% · 3.2 points below what the capital costs: growth destroys value
- Operating margin
- 11%
Operating margin · Medical Care Facilities median 8.9% · 12 months to Q2 2026
- Share count, year on year
- +1.5%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | 9.8% |
| FY2021 | 14% |
| FY2022 | 14% |
| FY2023 | 12% |
| FY2024 | 11% |
| FY2025 | 12% |
Details›
- Operating margin12 months to Q2 2026
- 11%
- Net margin12 months to Q2 2026
- −2.6%
- Free cash flow margin
- 5.6%
- Revenue, trailing twelve months
- $3.37B
- Free cash flow, trailing twelve months
- $188M
- Net income, trailing twelve months
- −$89M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 5.8%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.